Skip to Content
Skip to Footer
en-us
italiano
Sign In
Istituto Superiore di Sanità
Follow us on
About Us
Mission
Departments
National centres and Reference centres
Technical-scientific Services
History
Organization
Single guarantee committee
Regulations
ISS staff
Topics
Nutrition and food safety
Climate, environment and health
Dependencies
Medicines, vaccines and advanced therapies
Fertility
Gender and health
Clinical governance, National guidelines system (SNLG) and HTA
Chronic diseases and aging
Infectious diseases, HIV
Neurological diseases
Rare diseases
Prevention and health promotion
Radiation protection
Women's, children's and adolescents' health
Global health and health inequalities
Mental health
Veterinary public health
Chemical substances and health protection
Innovative technologies for health and telemedicine
Tumors
Activities
Databases
International collaborations
National Ethics Committee
Training
ISS-G20 Laboratorium
Reference laboratories
Guidelines - SNLG
Museum
Notified body
Projects
Publications
Registers and surveillance
Networks
School
Servizio Civile Universale
Phase 1 clinical trials
Services and Utilities
Meeting rooms
Calls and competitions
Library
Patronage
Intellectual property
Fares and paid services
Publications
Publications
Annali
Bollettino epidemiologico nazionale
Notiziario
Rapporti ISTISAN
Rapporti ISS Sorveglianza
ISS Activity Reports
ISS policy documents
Monographs
ISTISAN Congressi
Strumenti di riferimento
Rapporti ISS COVID-19
Rapporti ISS COVID-19 in English
Rapporti ISS COVID-19 en Español
Beni storico-scientifici
Dispense per la scuola
Consensus ISS
Leaflets
Historical videos
Ceased publications
Press Room
Home Page
About us
Press notes
News
Press releases
Press review
Special on COVID-19
Events
Digitale
Events
Conferences and seminars
Dissemination events
Webinar
ISSalute
Transparent administration
Tender notices
Data protection
MENU
Istituto Superiore di Sanità
About Us
Mission
Departments
National centres and Reference centres
Technical-scientific Services
History
Organization
Single guarantee committee
Regulations
ISS staff
Topics
Nutrition and food safety
Climate, environment and health
Dependencies
Medicines, vaccines and advanced therapies
Fertility
Gender and health
Clinical governance, National guidelines system (SNLG) and HTA
Chronic diseases and aging
Infectious diseases, HIV
Neurological diseases
Rare diseases
Prevention and health promotion
Radiation protection
Women's, children's and adolescents' health
Global health and health inequalities
Mental health
Veterinary public health
Chemical substances and health protection
Innovative technologies for health and telemedicine
Tumors
Activities
Databases
International collaborations
National Ethics Committee
Training
ISS-G20 Laboratorium
Reference laboratories
Guidelines - SNLG
Museum
Notified body
Projects
Publications
Registers and surveillance
Networks
School
Servizio Civile Universale
Phase 1 clinical trials
Services and Utilities
Meeting rooms
Calls and competitions
Library
Patronage
Intellectual property
Fares and paid services
Publications
Publications
Annali
Bollettino epidemiologico nazionale
Notiziario
Rapporti ISTISAN
Rapporti ISS Sorveglianza
ISS Activity Reports
ISS policy documents
Monographs
ISTISAN Congressi
Strumenti di riferimento
Rapporti ISS COVID-19
Rapporti ISS COVID-19 in English
Rapporti ISS COVID-19 en Español
Beni storico-scientifici
Dispense per la scuola
Consensus ISS
Leaflets
Historical videos
Ceased publications
Press Room
Home Page
About us
Press notes
News
Press releases
Press review
Special on COVID-19
Events
Digitale
Events
Conferences and seminars
Dissemination events
Webinar
ISSalute
Transparent administration
Tender notices
Data protection
Search Results - Home
Search
Search
Asset Entries
Any Asset
Web Content Article
(26)
Time
Any Time
Past Hour
(0)
Past 24 Hours
(0)
Past Week
(0)
Past Month
(0)
Past Year
(1)
Custom Range…
From
To
Search
No results were found that matched the keywords:
decessi covid-2019
.
Search
How is vaccine efficacy calculated?
Web Content Article
that vaccine efficacy in preventing any symptomatic or asymptomatic diagnosis of
COVID
Newsroom:
Special on COVID-19
Special on COVID-19 » Vaccini
Special on COVID-19 » Vaccini » FAQ vaccini
How does a viral vector-based vaccine workHow does a viral vector-based vaccine work?
Web Content Article
technology is the same as that behind the first vaccine approved for Ebola in late
2019
Newsroom:
Special on COVID-19 » Vaccini
Special on COVID-19 » Vaccini » FAQ vaccini
Fake news sui vaccini anti
Covid
ai bambini
Web Content Article
This result comes from the Italian version of this content.
Iss 10 dicembre 2021 - I bambini non si ammalano di
Covid
e se si ammalano non muoiono...263mila casi, 1453 ricoveri in reparti ordinari, 36 ricoveri in Terapia Intensiva...
Newsroom:
Special on COVID-19
Special on COVID-19 » Vaccini
Special on COVID-19 » Vaccini » Fake news
Impatto della vaccinazione
COVID
-19 sul rischio di infezione da SARS-CoV-2 e successivo...ricovero e
decesso
in Italia
Web Content Article
This result comes from the Italian version of this content.
congiunta dei dati dell’anagrafe nazionale vaccini e della sorveglianza integrata
COVID
...La valutazione del rischio di
COVID
-19 arriva ad oltre...
Newsroom:
Special on COVID-19
Special on COVID-19 » Vaccini
Special on COVID-19 » Vaccini » Cosa fa l'ISS
Covid
: dall'Iss un vademecum contro le fake news sui vaccini
Web Content Article
This result comes from the Italian version of this content.
il vaccino protegge dalle conseguenze peggiori della malattia, dal ricovero al
decesso
..."Vengono nascosti effetti collaterali e
decessi
post...
Newsroom:
Press notes
Special on COVID-19
Special on COVID-19 » Vaccini
Special on COVID-19 » Vaccini » Fake news
Non mi vaccino contro
Covid
-19 perché il monitoraggio sulla sicurezza del vaccino
Web Content Article
This result comes from the Italian version of this content.
Per i vaccini anti
COVID
-19, invece, le relazioni sulla sicurezza devono essere inviate
Newsroom:
Special on COVID-19
Special on COVID-19 » Vaccini
Special on COVID-19 » Vaccini » Fake news
Il booster nella fascia di età 12-39 induce una perdita di protezione rispetto a chi ha fatto solo due dosi
Web Content Article
This result comes from the Italian version of this content.
aver ricevuto il booster e una maggiore probabilità di essere ospedalizzati (e di
decesso
Newsroom:
Special on COVID-19
Special on COVID-19 » Vaccini
Special on COVID-19 » Vaccini » Fake news
I vaccini anti Sars-CoV-2 sono stati preparati troppo in fretta e non sono sicuri
Web Content Article
This result comes from the Italian version of this content.
FALSO. I vaccini sono approvati dalle Autorità competenti solo dopo averne verificato i requisiti di qualità e sicurezza. L’Ema, l’Agenzia europea per i farmaci, ha approvato oggi il primo vaccino...
Newsroom:
Special on COVID-19 » Vaccini » Fake news
Special on COVID-19 » Vaccini
Special on COVID-19
È inutile vaccinarsi contro il Sars CoV-2 perché il virus è già mutato e il vaccino è inefficace
Web Content Article
This result comes from the Italian version of this content.
FALSO. Non vi è alcuna evidenza al momento che la mutazione del virus rilevata nel Regno Unito possa avere effetti sull’efficacia della vaccinazione. I vaccini determinano la formazione di una...
Newsroom:
Special on COVID-19 » Vaccini » Fake news
Special on COVID-19 » Vaccini
Special on COVID-19
I vaccini costano tanto, potranno vaccinarsi solo i ricchi
Web Content Article
This result comes from the Italian version of this content.
Falso. I vaccini in Italia saranno resi disponibili gratuitamente per tutti i cittadini, a partire dalle categorie individuate come prioritarie. La vaccinazione, seppur con tempi diversi, sarà...
Newsroom:
Special on COVID-19 » Vaccini » Fake news
Special on COVID-19 » Vaccini
Special on COVID-19
Il vaccino a RNA è pericoloso perché modifica il codice genetico
Web Content Article
This result comes from the Italian version of this content.
FALSO. Il compito dell’mRNA è solo quello di trasportare le istruzioni per la produzione delle proteine da una parte all’altra della cellula, per questo si chiama “messaggero”. In questo caso...
Newsroom:
Special on COVID-19 » Vaccini » Fake news
Special on COVID-19 » Vaccini
Special on COVID-19
Il vaccino è inutile perché l’immunità dura solo poche settimane
Web Content Article
This result comes from the Italian version of this content.
FALSO. La protezione indotta dai vaccini, sulla base dei dati emersi durante le sperimentazioni, durerà alcuni mesi. Solo quando il vaccino sarà somministrato a larghe fasce di popolazione sarà...
Newsroom:
Special on COVID-19 » Vaccini » Fake news
Special on COVID-19 » Vaccini
Special on COVID-19
Like all vaccines, Sars-Cov-2 vaccines can also cause side effects. During the trial, common reactions were observed, that were previously reported with other vaccinations. However, all countries that have adopted the vaccine, including Italy, have put in place a surveillance system for the reporting of adverse effects.
Web Content Article
In addition to not having the "instructions" to modify DNA, messenger RNA never enters the nucleus of the cell, which contains the genome; this means that messenger RNA can in no way alter DNA....
Newsroom:
Special on COVID-19 » Vaccini » FAQ vaccini
Special on COVID-19 » Vaccini
Special on COVID-19
What evidence is there of their safety, since they were approved so quickly?
Web Content Article
The tests required by the authorities and carried out on the candidate vaccines against Sars-Cov-2 are the same as for all the other previously approved drugs and vaccines. In Europe, it was...
Newsroom:
Special on COVID-19 » Vaccini » FAQ vaccini
Special on COVID-19 » Vaccini
Special on COVID-19
Are vaccines against Sars-CoV-2 effective
Web Content Article
In order to be approved by the regulatory authorities, all vaccines must have proven to be effective. Human trials of several dozen other candidates are underway around the world, some of which are...
Newsroom:
Special on COVID-19 » Vaccini » FAQ vaccini
Special on COVID-19 » Vaccini
Special on COVID-19
How long after being vaccinated doHow long after being vaccinated does an individual acquire protection against the virus?
Web Content Article
The efficacy observed in clinical trials refers to a few days after the administration of the second dose. Therefore, maximum protection occurs after this period. Although, according to preliminary...
Newsroom:
Special on COVID-19
Special on COVID-19 » Vaccini
Special on COVID-19 » Vaccini » FAQ vaccini
How does the risk of infection vary over time after vaccination?
Web Content Article
October 8th 2021 - When the first dose of the vaccine is administered, the risk of infection is the same as for unvaccinated persons because the immune system needs a few weeks to give rise to the...
Newsroom:
Special on COVID-19
Special on COVID-19 » Vaccini
Special on COVID-19 » Vaccini » FAQ vaccini
What are the side effects?
Web Content Article
December 12th 2021 - Like all vaccines, Sars-Cov-2 vaccines can also cause side effects. During the trial, common reactions were observed, that were previously reported with other vaccinations....
Newsroom:
Special on COVID-19 » Vaccini » FAQ vaccini
Special on COVID-19 » Vaccini
Special on COVID-19
RNA based vaccines will be used for the first time. What does that mean?
Web Content Article
December 24th 2020 - In a vaccine, the 'weakened' virus (or bacterium), or a part of it, is usually injected. The immune system recognizes the 'intruder' and produces antibodies that it will use...
Newsroom:
Special on COVID-19 » Vaccini » FAQ vaccini
Special on COVID-19 » Vaccini
Special on COVID-19
In Italia i vaccini contro Sars-CoV-2 non arriveranno mai perché non sono stati ancora acquistati
Web Content Article
This result comes from the Italian version of this content.
FALSO. L’Italia è stata tra i primi Paesi al mondo a opzionare le quantità di vaccini necessarie per la somministrazione a tutta la popolazione. L’Italia infatti con Francia, Germania ed Olanda è...
Newsroom:
Special on COVID-19 » Vaccini » Fake news
Special on COVID-19 » Vaccini
Special on COVID-19
20 Entries
Per Page
4
Entries per Page
8
Entries per Page
20
Entries per Page
40
Entries per Page
60
Entries per Page
Showing 21 to 26 of 26 entries.
Previous Page
Page
1
Page
2
Next Page
Hidden